The Indiana PROSPECT builds on the nation's largest, most sophisticated health information exchange that already contains over 2.5 billion structured observations and 38 million text documents for over 10 million patients. This resource is already used for a variety of clinical outcomes and clinical effectiveness research. Based on our analysis of gaps in the infrastructure and experience gained by conducting a specific CER study as part of the PROSPECT, we will enhance this infrastructure to capture richer clinical data and particularly enhance our ability to incorporate patient outcomes, improved capture of device utilization data, capabilities to incorporate genomic and other high throughput results, advanced technologies to identify patient for recruitment and enrollment technologies. In order to demonstrate the usability of this environment and to inform its further development, we propose to conduct a novel CER project evaluating treatment for Alzheimer's. The CER study will evaluate of medication treatment for behavioral symptoms of Alzheimer's disease. Alzheimer's disease has been identified as a first quartile CER priority. Because our approach is population based, we will incorporate a significant minority population. This application represents collaboration between the Medical Informatics Program at the Regenstrief Institute, Inc (a world leader in health information technology) and two Indiana University research programs: the Center for Aging Research and the Division of Clinical Pharmacology. These programs have an established track record in research relevant to under-served populations. Thus, this application combines considerable investigator, environment, and research strengths to continue to build a novel CER infrastructure in support of the nation's evidentiary CER priorities. We will build on our established governance approach to test and improve approaches for sharing access to these research databases and financial models for sustainability based on value created.

Public Health Relevance

Project Narrative This proposal seeks to enhance the existing information technology infrastructure in Central Indiana to improve the nation's capacity to conduct comparative effectiveness research (CER) and apply these new capacities to a novel CER project evaluating treatment for Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Project (R01)
Project #
1R01HS019818-01
Application #
8033049
Study Section
Special Emphasis Panel (ZHS1-HSR-A (04))
Program Officer
Randhawa, Gurvaneet
Project Start
2010-09-30
Project End
2013-09-29
Budget Start
2010-09-30
Budget End
2013-09-29
Support Year
1
Fiscal Year
2010
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Hicks, J K; Sangkuhl, K; Swen, J J et al. (2017) Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther 102:37-44
Campbell, Noll L; Skaar, Todd C; Perkins, Anthony J et al. (2015) Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy. Clin Interv Aging 10:269-75
Mehrabi, Saeed; Krishnan, Anand; Sohn, Sunghwan et al. (2015) DEEPEN: A negation detection system for clinical text incorporating dependency relation into NegEx. J Biomed Inform 54:213-9
Roch, Alexandra M; Mehrabi, Saeed; Krishnan, Anand et al. (2015) Automated pancreatic cyst screening using natural language processing: a new tool in the early detection of pancreatic cancer. HPB (Oxford) 17:447-53
Schelleman, H; Han, X; Brensinger, C M et al. (2014) Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins. Br J Clin Pharmacol 78:639-48
Crews, K R; Gaedigk, A; Dunnenberger, H M et al. (2014) Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther 95:376-82
Wu, Heng-Yi; Karnik, Shreyas; Subhadarshini, Abhinita et al. (2013) An integrated pharmacokinetics ontology and corpus for text mining. BMC Bioinformatics 14:35
Hicks, J K; Swen, J J; Thorn, C F et al. (2013) Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin Pharmacol Ther 93:402-8
Jiang, Guanglong; Chakraborty, Arindom; Wang, Zhiping et al. (2013) New aQTL SNPs for the CYP2D6 identified by a novel mediation analysis of genome-wide SNP arrays, gene expression arrays, and CYP2D6 activity. Biomed Res Int 2013:493019
Campbell, Noll L; Dexter, Paul; Perkins, Anthony J et al. (2013) Medication adherence and tolerability of Alzheimer's disease medications: study protocol for a randomized controlled trial. Trials 14:125

Showing the most recent 10 out of 22 publications